Nathan Smith

Nathan Smith

McDermott Will & Emery

Contact  |  View Bio  |  RSS

Latest Publications


Gilead Warns: Examine Patent Portfolios for Double Patenting Pitfalls

Gilead Sciences, Inc. v. Natco Pharma Ltd. - Addressing invalidation of a patent for obviousness-type double patenting, the U.S. Court of Appeals for the Federal Circuit vacated and remanded a district court’s...more

6/2/2014 - Appeals Gilead Sciences Natco Pharma Obviousness Patent Litigation Patents Pharmaceutical Pharmaceutical Patents

When Is a Claimed Drug Formulation Enabled and Adequately Described?

Alcon Research Ltd. v. Barr Labs., Inc. - Addressing the requirements for enablement and written description, the U.S. Court of Appeals for the Federal Circuit reversed a district court’s ruling of patent invalidity,...more

5/5/2014 - ANDA Patent Applications Patent Litigation Patents Pharmaceutical Prescription Drugs Written Descriptions

IP Update, Vol. 16, No. 10, October 2013

No Case or Controversy in DJ Against Patentee Who Sued Manufacturer’s Customers: Cisco Systems, Inc. v. Alberta Telecommunications Research Center - In a non-precedential opinion addressing declaratory judgment...more

11/1/2013 - Cisco Claim Construction Copyright FRAND Offsets Patent Infringement Patent Litigation Patent-Eligible Subject Matter Patents Telecommunications Trademark Policing Trademarks

3 Results
View per page
Page: of 1